By comparison, after the intervention of high-dose IL-38, the expression of VEGF, VEGFR1 and VEGFR2 was more pronounced in the CLH group (P<0.05 vs CLL&CIA). This evidence concerns the gene IL1F10 and B-cell chronic lymphocytic leukemia.